Roughly 50% of cancer cases occur in people aged 65 years or older. Older people are
often diagnosed at a later stage and might receive less (intensive) treatment, which might …

Despite substantial improvements in the outcomes of patients with cancer over the past two
decades, older adults (aged≥ 65 years) with cancer are a rapidly increasing population and …

Purpose Polypharmacy is prevalent in older adults starting cancer treatment and associated
with potentially inappropriate medications (PIM), potential drug-drug interactions (DDI), and …

Background Polypharmacy is common in older adults who are starting cancer treatment and
is associated with an increased risk of potentially inappropriate medications (PIMs) and …

The treatment cannot be worse than the disease is an oft-cited statement representing the
important concept of tolerability; older patients often express concerns about side effects …

Background: Older people often receive multiple medications for chronic conditions, which
often result in polypharmacy (concomitant use of 5‒9 medicines) and hyperpolypharmacy …

Objectives: Polypharmacy and potentially inappropriate medication (PIM) use among elderly
Chinese patients have not yet been investigated by systematic review and meta-analysis …

Abstract Background and Aim: Polypharmacy and potentially inappropriate medication (PIM)
use in older populations (65+ years) have not yet been investigated by meta-analyses in …

Background: Polypharmacy and potentially inappropriate medications (PIMs) are common
among older adults with blood cancers, but their association with frailty and how to manage …

Background Both polypharmacy and potentially inappropriate medication (PIM) intake are
highly prevailing in older cancer patients. However, only studies on the association of …